MENU
+Compare
LFCR
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$7.89
Change
-$0.33 (-4.01%)
Capitalization
295.61M

LFCR Lifecore Biomedical Forecast, Technical & Fundamental Analysis

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges... Show more

LFCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for LFCR with price predictions
Nov 12, 2025

Aroon Indicator for LFCR shows an upward move is likely

LFCR's Aroon Indicator triggered a bullish signal on November 12, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 176 similar instances where the Aroon Indicator showed a similar pattern. In of the 176 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 07, 2025. You may want to consider a long position or call options on LFCR as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LFCR just turned positive on October 21, 2025. Looking at past instances where LFCR's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

LFCR moved above its 50-day moving average on November 10, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LFCR crossed bullishly above the 50-day moving average on November 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where LFCR advanced for three days, in of 271 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LFCR broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LFCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LFCR's P/B Ratio (192.308) is slightly higher than the industry average of (18.827). P/E Ratio (51.231) is within average values for comparable stocks, (71.764). LFCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). LFCR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (2.132) is also within normal values, averaging (39.291).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
LFCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

LFCR is expected to report earnings to fall 44.83% to -15 cents per share on January 01

Lifecore Biomedical LFCR Stock Earnings Reports
Q4'25
Est.
$-0.16
Q3'25
Beat
by $0.03
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.33
Q4'24
Beat
by $0.02
The last earnings report on November 06 showed earnings per share of -28 cents, beating the estimate of -31 cents. With 212.64K shares outstanding, the current market capitalization sits at 295.61M.
A.I. Advisor
published General Information

General Information

a manufacturer of polymer products for food and agricultural products, medical devices and licensed partner applications

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Industrial Specialties
Address
3515 Lyman Boulevard
Phone
+1 952 368-4300
Employees
459
Web
https://www.lifecore.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNPQY40.171.07
+2.74%
BNP Paribas
ELKEF2.60N/A
N/A
Elkem ASA
KNCRF92.10N/A
N/A
Konecranes Plc
BKUT510.00N/A
N/A
Bank of Utica (NY)
ECGS0.28-0.05
-13.90%
Eco-Growth Strategies Inc.

LFCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+6.20%
NBIX - LFCR
36%
Loosely correlated
-0.30%
SHPH - LFCR
31%
Poorly correlated
-0.79%
AMRX - LFCR
31%
Poorly correlated
-0.42%
ZTS - LFCR
29%
Poorly correlated
+0.94%
KMDA - LFCR
28%
Poorly correlated
+3.12%
More

Groups containing LFCR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+6.20%
Pharmaceuticals: Generic
industry (214 stocks)
33%
Loosely correlated
-1.00%